Neoplastic stromal cells of intracranial hemangioblastomas disclose pericyte-derived mesenchymal stromal cells-like phenotype

Korean Journal of Pathology

Volumn 45, Issue 6, 2011, Pages 564-572

  Jung, Yong Han ^a   Kim, Jeong ^a   Kim, Bo Mi ^a   Kim, Eun Kyoung ^a   Kang, Mi Seon ^a   Jung, Soojin ^a   Yang, Young Il ^a,b   Khang, Shin Kwang ^c  

^a Inje University College of Medicine   (South Korea)

^b Inje University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Hemangioblastoma; Immunophenotype; Mesenchymal stromal cells; Pericytes; Stromal cells

Indexed keywords

EID: 84863013559     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2011.45.6.564     Document Type: Article

References (30)

1. Lee JY, Dong SM, Park WS, et al. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 1998; 58: 504-8.
2. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, et al. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 1997; 28: 540-3.
3. Zagzag D, Krishnamachary B, Yee H, et al. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 2005; 65: 6178-88.
4. Alles JU, Bosslet K, Schachenmayr W. Hemangioblastoma of the cerebellum: an immunocytochemical study. Clin Neuropathol 1986; 5: 238-41.
5. Bleistein M, Geiger K, Franz K, Stoldt P, Schlote W. Transthyretin and transferrin in hemangioblastoma stromal cells. Pathol Res Pract 2000; 196: 675-81.
6. Mizuno J, Iwata K, Takei Y. Immunohistochemical study of hemangioblastoma with special reference to its cytogenesis. Neurol Med Chir (Tokyo) 1993; 33: 420-4.
7. Nemes Z. Fibrohistiocytic differentiation in capillary hemangioblastoma. Hum Pathol 1992; 23: 805-10.
8. Gläsker S, Li J, Xia JB, et al. Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res 2006; 66: 4167-72.
9. Park DM, Zhuang Z, Chen L, et al. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med 2007; 4: e60.
10. Krueger M, Bechmann I. CNS pericytes: concepts, misconceptions, and a way out. Glia 2010; 58: 1-10.
11. Abedin M, Tintut Y, Demer LL. Mesenchymal stem cells and the artery wall. Circ Res 2004; 95: 671-6.
12. Covas DT, Panepucci RA, Fontes AM, et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivas-cular cells and fibroblasts. Exp Hematol 2008; 36: 642-54.
13. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-13.
14. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008; 26: 2287-99.
15. Yang YI, Kim HI, Choi MY, et al. Ex vivo organ culture of adipose tissue for in situ mobilization of adipose-derived stem cells and defining the stem cell niche. J Cell Physiol 2010; 224: 807-16.
16. Lach B, Gregor A, Rippstein P, Omulecka A. Angiogenic histogenesis of stromal cells in hemangioblastoma: ultrastructural and immunohistochemical study. Ultrastruct Pathol 1999; 23: 299-310.
17. Lin JJ, Lin F. Two entities in angiolipoma: a study of 459 cases of lipoma with review of literature on infiltrating angiolipoma. Cancer 1974; 34: 720-7.
18. Mills SE, Cooper PH, Fechner RE. Lobular capillary hemangioma: the underlying lesion of pyogenic granuloma: a study of 73 cases from the oral and nasal mucous membranes. Am J Surg Pathol 1980; 4: 470-9.
19. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors. 5th ed. Philadelphia: Mosby-Elsevier, 2008; 437-40.
20. Toida M, Hasegawa T, Watanabe F, et al. Lobular capillary hemangioma of the oral mucosa: clinicopathological study of 43 cases with a special reference to immunohistochemical characterization of the vascular elements. Pathol Int 2003; 53: 1-7.
21. Adams SA, Hilton DA. Recurrent haemangioblastoma with glial differentiation. Neuropathol Appl Neurobiol 2002; 28: 142-6.
22. Shimura T, Hirano A, Llena JF. Ultrastructure of cerebellar hemangioblastoma: some new observations on the stromal cells. Acta Neuropathol 1985; 67: 6-12.
23. Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor. Mod Pathol 1989; 2: 638-51.
24. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-7.
25. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002; 160: 985-1000.
26. Dore-Duffy P, Katychev A, Wang X, Van Buren E. CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab 2006; 26: 613-24.
27. Oishi K, Ito-Dufros Y. Angiogenic potential of CD44+ CD90+ multipotent CNS stem cells in vitro. Biochem Biophys Res Commun 2006; 349: 1065-72.
28. Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006; 24: 1605-12.
29. Jung SM, Kuo TT. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol 2005; 18: 788-94.
30. Mahmood A, Harkness L, Schrøder HD, Abdallah BM, Kassem M. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. J Bone Miner Res 2010; 25: 1216-33.